Advertisement
SAN ANTONIO, Aug. 02, 2018 /PRNewswire-PRWeb/ -- Kalypso Wellness Centers, one of the most successful, and rapidly expanding, ketamine clinics in the country, has expanded into the Northeastern United States through a partnership with Dr. Edward S. Rubin M.D. and his Infusion Wellness Center in Garden City, New York. The partnership with Kalypso will provide Kalypso Ketamine™ formulations that will benefit his chronic pain patients and give 9/11 victims more treatment options.
For more than 10 years, Dr. Rubin has been passionate about helping 9/11 victims manage chronic pain, both physical and emotional, through his affiliation with the World Trade Center Fund. Recent research found that more than 16 years after completing cleanup at the World Trade Center complex, many who worked at the site have an elevated risk of heart attack and stroke due to their continued struggle with PTSD.
"Kalypso and Infusion Wellness are aligned in our goal to provide high quality care, greater access to treatment and an evidence-based approach," Rubin said. "I believe that this strategic alliance can help both of us to achieve our visions faster as partners."
President of the NY Society of Interventional Pain Physicians, who is actively involved in medical research, Dr. Rubin began offering innovative Kalypso Ketamine™ formulations in July. He has been working with the team from Kalypso to ensure the same procedures are in place that allow for their great success.
"We are thrilled to announce this partnership with Infusion Wellness and to have a presence in New York," said Dr. Scott Worrich, Chief Clinical Officer of Kalypso Wellness Centers. "This is exactly what we had in mind two years ago when we started Kalypso, to give people all over the country who are suffering from chronic pain, PTSD, depression, and other conditions treatment options they can't get elsewhere. We have not stopped growing since we started in 2016 and we are going to continue to look to expand further throughout the U.S."
Kalypso's rapid expansion has been largely due to the success of its Kalypso Ketamine™ infusions in managing chronic pain, depression, PTSD, migraines, and other disease states. Kalypso's unique formulations have resulted in 90-96% efficacy, and Kalypso's proprietary formulations dramatically reduce the side effect rate of ketamine treatments to only 5%. Earlier this year, Kalypso reached a milestone when it administered its 3,000th ketamine infusion. About Kalypso Wellness Centers Kalypso Wellness Centers was formed in 2016 by two board certified anesthesiologists Dr. Cannon Clifton, CEO and Dr. Bryan Clifton, CMO; and two board certified pain management physicians, Dr. Mark Moran, Chief Science Officer and Dr. Scott Worrich, Chief Clinical Officer who were tired of seeing patients needlessly suffering and chronically debilitated on prescription narcotics. After countless months of research, they found a promising new solution with the use of ketamine infusions that could be offered to patients. As treatments continued, they created the RESET Ketamine Therapy™, which includes five distinct proprietary ketamine formulations: KalyCalm™, KalyCan™, KalyMax™, KalyPro™ and KalyZen™. Upon further investigation, they discovered that when tailored to each patient's unique disease state, these infusions can provide a substantial improvement in quality of life for patients with anxiety, major depressive disorder, PTSD, bipolar disorder, fibromyalgia, neuropathic pain, inflammatory pain, chronic pain, and migraines/chronic headaches. For more information, visit http://www.kalypsowellness.com.
About Infusion Wellness/The Pain Management Practice of Dr. Edward S. Rubin The Pain Management practice of Dr. Edward S. Rubin, serves the needs of Nassau County and Queens, New York, and offers interventional pain management treatment options for patients with acute and chronic pain. While we specialize in spine pain, our physician, Dr. Edward Rubin, and his team treats many other conditions such as fibromyalgia, cancer pain, chronic pelvic pain and complex regional pain syndrome.
For more information, visit https://edrubinmd.com/.
SOURCE Lux214 Media Group
Advertisement
For more than 10 years, Dr. Rubin has been passionate about helping 9/11 victims manage chronic pain, both physical and emotional, through his affiliation with the World Trade Center Fund. Recent research found that more than 16 years after completing cleanup at the World Trade Center complex, many who worked at the site have an elevated risk of heart attack and stroke due to their continued struggle with PTSD.
"Kalypso and Infusion Wellness are aligned in our goal to provide high quality care, greater access to treatment and an evidence-based approach," Rubin said. "I believe that this strategic alliance can help both of us to achieve our visions faster as partners."
President of the NY Society of Interventional Pain Physicians, who is actively involved in medical research, Dr. Rubin began offering innovative Kalypso Ketamine™ formulations in July. He has been working with the team from Kalypso to ensure the same procedures are in place that allow for their great success.
"We are thrilled to announce this partnership with Infusion Wellness and to have a presence in New York," said Dr. Scott Worrich, Chief Clinical Officer of Kalypso Wellness Centers. "This is exactly what we had in mind two years ago when we started Kalypso, to give people all over the country who are suffering from chronic pain, PTSD, depression, and other conditions treatment options they can't get elsewhere. We have not stopped growing since we started in 2016 and we are going to continue to look to expand further throughout the U.S."
Kalypso's rapid expansion has been largely due to the success of its Kalypso Ketamine™ infusions in managing chronic pain, depression, PTSD, migraines, and other disease states. Kalypso's unique formulations have resulted in 90-96% efficacy, and Kalypso's proprietary formulations dramatically reduce the side effect rate of ketamine treatments to only 5%. Earlier this year, Kalypso reached a milestone when it administered its 3,000th ketamine infusion. About Kalypso Wellness Centers Kalypso Wellness Centers was formed in 2016 by two board certified anesthesiologists Dr. Cannon Clifton, CEO and Dr. Bryan Clifton, CMO; and two board certified pain management physicians, Dr. Mark Moran, Chief Science Officer and Dr. Scott Worrich, Chief Clinical Officer who were tired of seeing patients needlessly suffering and chronically debilitated on prescription narcotics. After countless months of research, they found a promising new solution with the use of ketamine infusions that could be offered to patients. As treatments continued, they created the RESET Ketamine Therapy™, which includes five distinct proprietary ketamine formulations: KalyCalm™, KalyCan™, KalyMax™, KalyPro™ and KalyZen™. Upon further investigation, they discovered that when tailored to each patient's unique disease state, these infusions can provide a substantial improvement in quality of life for patients with anxiety, major depressive disorder, PTSD, bipolar disorder, fibromyalgia, neuropathic pain, inflammatory pain, chronic pain, and migraines/chronic headaches. For more information, visit http://www.kalypsowellness.com.
About Infusion Wellness/The Pain Management Practice of Dr. Edward S. Rubin The Pain Management practice of Dr. Edward S. Rubin, serves the needs of Nassau County and Queens, New York, and offers interventional pain management treatment options for patients with acute and chronic pain. While we specialize in spine pain, our physician, Dr. Edward Rubin, and his team treats many other conditions such as fibromyalgia, cancer pain, chronic pelvic pain and complex regional pain syndrome.
For more information, visit https://edrubinmd.com/.
SOURCE Lux214 Media Group
